Navigation Links
Novel Compound Shows Promise for Treatment of Alcoholism
Date:9/11/2008

discovery of new therapeutic compounds for treating alcoholism and related disorders."

The Preclinical Development Group that Dr. Bartlett leads at the UCSF-affiliated Gallo Center was established to develop new treatments and bridge the gap between research and clinical treatment. The purpose of the study was to find improved compounds for the treatment of alcoholism. "The study results demonstrate that this compound causes selective and long-lasting reductions of ethanol consumption and suggests the compound might be a promising candidate as a novel treatment for alcoholism. This study indicates that compounds with a higher affinity for delta opioid receptors and reduced affinity for mu opioid receptors might be better treatment candidates than Naltrexone, the current FDA approved treatment for alcoholism", said Dr. Bartlett.

"The study on SoRI-9409 and alcohol cessation has yielded vital data that will help fuel novel treatments for a devastating and very difficult-to-treat illness," said Dr. Bartlett. "To date, we have considered and evaluated other compounds, and theories, but the information yielded from this study, along with previous research on this particular compound, has proven to be the most promising to date. We are looking forward to collaborating with our partner, Southern Research, to enter the next phase of research." The research was also supported by the State of California for Medical Research on Alcohol and Substance Abuse and Department of Defense.

Southern Research operates a successful drug discovery research program resulting in six FDA approved drugs with six additional drug candidates in late-stage preclinical and early clinical development.

"Much of our success stems from having a highly successful medicinal chemistry group, and seeking out collaborators who are driven to help us develop new lead compounds and bring those drugs to market," said David Harris, director of Business Development for the Drug Disco
'/>"/>

SOURCE Southern Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Major State Grant Accelerates Research and Development of Novel Cancer Therapy
2. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
3. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
4. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
5. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
6. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
7. Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
8. Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
9. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
10. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
11. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015  Flexpoint Sensor Systems, Inc. (OTCBB: ... it has received and shipped during the last 90 ... of interest in the sensors for gloves and medical ... have had custom sensors built for them. Some of ... custom sensors for medical rehab; a major international electronics ...
(Date:3/26/2015)... , March 26, 2015  Oxis ... of Oxis International, Inc. [OTC: OXIS] and ... of an exclusive option agreement with the ... properties developed by Dr. Xiang-Qun Xie ... Professor, Pharmaceutical Sciences, School of Pharmacy.  These ...
(Date:3/26/2015)... 26, 2015 Gelesis , a ... of first-in-class products to induce weight loss and ... an equity financing of shares of convertible preferred ... including the conversion of approximately $4 million of ... will be used to support the continued clinical ...
Breaking Medicine Technology:Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3Gelesis Closes $22M Equity Financing 2Gelesis Closes $22M Equity Financing 3
... 2007--Sciele Pharma, Inc.,(NASDAQ:SCRX) today announced the successful completion ... formulation. The study,results showed that the new Sular ... new Sular formulation,utilizes SkyePharma's (LSE:SKP) patented Geomatrix technology,which ... Sular for each of its,current doses. , The ...
... Calif.--(BUSINESS WIRE)--May 14, 2007 - Oculus Innovative,Sciences, ... was the subject of a poster presentation ... that was held in,Glasgow, Scotland this past ... an Antimicrobial,Solution in the Treatment of Infected ...
Cached Medicine Technology:Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 2Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 3Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program 4Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3
(Date:3/27/2015)... “ VXi BlueParott Reveal ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... eliminating 90% of ambient noise. , Today, business is ... are important to any professional, voice calls are just ...
(Date:3/27/2015)... The Florida Center for Brain Tumor ... (ABC2), awarded $350,000 to support brain cancer research at ... Research Institute and H. Lee Moffitt Cancer Center and ... clear development path and potential to provide meaningful improvements ... , The awards fund research in areas on ...
(Date:3/27/2015)... 2015 The Thomas Scattergood ... grant-making foundation committed to raising its voice to ... delivered. , The Scattergood Foundation and The Kennedy ... Policy and Practice through the Annual Scattergood Foundation ... App is designed to guide the IBS sufferer ...
(Date:3/26/2015)... Elfster.com, the top-rated Secret Santa generator, ... list generator capabilities to its leading Secret Santa list ... list that one creates of things to do before ... the same name. Nowadays many millennials are creating ... summer achievements. , "We are greatly expanding our technology ...
(Date:3/26/2015)... 26, 2015 Dr. Rod J. ... Dallas Rhinoplasty Symposium and has trained over 6500 ... importance of evidence based medicine (EBM), that is, the ... conducted research. , "We often hear from rhinoplasty ... while we are certainly not trying to stifle these ...
Breaking Medicine News(10 mins):Health News:A Device to Tune out Background Noise was Recently Featured on NewsWatch Television 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:SoundsLikeIBS Nominated For 3rd Annual Scattergood Innovation Award 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2
... under constant stress, could severely damage major organs and ... have warned. ,Stress may lead to unhealthy ... too much alcohol and not getting enough exercise - ... ,For some people, being under constant stress can ...
... of tea daily can protect you from developing skin cancer, ... to strengthen the findings. ,Tea's disease-fighting properties appear ... cell carcinomas - most common forms of skin cancers usually ... that grow slowly over a period of months or even ...
... found in human blood inhibited 60 strains of HIV ... study published Thursday in the journal Cell//, the San ... HIV strains that have developed resistance to existing medications ... new HIV/AIDS drugs -- the Chronicle reports. ...
... when thirty poor women of the fishing community, living on ... The 1994 Transplant of Human Organ Act ... allowed to donate kidneys for transplantation. However a recent report ... indicate that several leading hospitals in the state encouraged the ...
... Approximately 50% of sexually active gay men in the UK had ... of the 2005 Gay Men’s Sex Survey//, Consuming Passions, which has ... 40% of gay men in the UK are unaware of their ... have not disclosed their HIV infection status. ,The ...
... 4,000 pregnant women one-fifth of them had to undergo emergency ... Researchers found that obesity impairs the ability of the uterus ... deliver the baby. ,In a study of 4,000 ... women had to undergo an emergency Caesarean Section birth because ...
Cached Medicine News:Health News:Modern Lifestyle Could Damage Heart 2Health News:Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says 2Health News:Kidney Trade: Curbing the Sale 2Health News:Kidney Trade: Curbing the Sale 3Health News:One-fifth of Obese Women Undergo Caesarean Due to Uterus Failure 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: